Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2007-000733-19 | EudraCT Number |
Not provided
Not provided
Analysis of data from 104RA202 failed to meet primary endpoint
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To observe the long-term treatment with BG9924 when administered to participants with RA who previously participated in a Biogen Idec Study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group 2 | Experimental | Drug: BG9924 - dose administered as per Biogen-Idec protocol |
|
| Group 1 | Experimental | Drug: BG9924 - dose administered as per Biogen-Idec protocol |
|
| Group 3 | Experimental | Drug: BG9924 - dose administered as per Biogen-Idec protocol |
|
| Group 4 | Experimental | Drug: BG9924 - dose administered as per Biogen-Idec protocol |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Baminercept alfa (BG9924) | Biological | dosage administered as per Biogen-Idec protocol |
|
| Measure | Description | Time Frame |
|---|---|---|
| To Observe The Long-Term treatment with BG9924 When Administered to Participants with RA who Previously Participated in a Biogen Idec Study | Duration of this study is 18 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Medical Director | Biogen | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Coordinating Research Site | San Miguel de Tucumán | T4000AXL | Argentina | |||
| Coordinating Research Site |
Not provided
| ID | Term |
|---|---|
| D001172 | Arthritis, Rheumatoid |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C000599771 | baminercept |
| D053308 | Lymphotoxin-beta |
| ID | Term |
|---|---|
| D048069 | Tumor Necrosis Factors |
| D016207 | Cytokines |
| D036341 | Intercellular Signaling Peptides and Proteins |
| D010455 | Peptides |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| São Paulo |
| Brazil |
| Coordinating Research Site | Budapest | H-1036 | Hungary |
| Coordinating Research Site | Cuernavaca | 62270 | Mexico |
| Coordinating Research Site | Torun | 87-100 | Poland |
| Coordinating Research Site | Brăila | 810112 | Romania |
| Coordinating Research Site | Moscow | 127644 | Russia |
| Coordinating Research Site | Leeds | Yorkshire | LS74SA | United Kingdom |
| D003240 |
| Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D000602 | Amino Acids, Peptides, and Proteins |
| D011506 | Proteins |
| D001685 | Biological Factors |